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Abstract TATA box binding protein (TBP)^promoter interac-
tion nucleates assembly of the RNA polymerase II transcription
initiation complex. Transcription factor IIA (TFIIA) stabilizes
the TBP^promoter complex whereas the N-terminal domain of
the largest TAFII inhibits TBP^promoter interaction. We have
mapped the interaction sites on TBP of Drosophila TAFII230
and yeast TFIIA (comprising two subunits, TOA1 and TOA2),
using nuclear magnetic resonance (NMR), and also report
structural evidence that subdomain II of the TAFII230 N-
terminal inhibitory domain and TFIIA have overlapping binding
sites on the convex surface of TBP. Together with previous
mutational and biochemical data, our NMR results indicate that
subdomain II augments subdomain I-mediated inhibition of TBP
function by blocking TBP-TFIIA interaction.
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1. Introduction
Initiation of transcription by RNA polymerase II requires
the auxiliary transcription factors (TF) IIA, TFIIB, TFIID,
TFIIE, TFIIF and TFIIH [1]. The TATA box binding protein
(TBP) subunit of TFIID nucleates assembly of the RNA poly-
merase II complex through its sequence-speci¢c recognition
and binding of the TATA element of the core promoter.
TFIIA stimulates and stabilizes TBP binding to TATA-con-
taining DNA [2] by direct interaction with TBP and DNA
[3,4]. In the step-wise model of transcription complex assem-
bly based on in vitro studies [5,6], subsequent ordered assem-
bly of TFIIB, the RNA polymerase II^TFIIF complex and
TFIIE and TFIIH completes transcription initiation complex
formation.
Structural studies of the RNA polymerase II auxiliary fac-
tors have contributed greatly to our understanding of the
macromolecular interactions supporting assembly of the
RNA polymerase II transcription initiation complex. The
crystal structures of TBP [7,8] and the TBP^TATA box com-
plex [9,10] revealed a large concave undersurface on TBP
formed by a curved, eight-stranded, antiparallel L-sheet which
makes minor groove and phosphate-ribose contacts and indu-
ces partial unwinding of the eight base pair TATA element. In
the TFIIA^TBP^TATA ternary complex crystal structure
[3,4], the principal TFIIA^TBP interface involves the outer
L-strand of TBP leading to the N-terminal stirrup of TBP.
Mutagenesis and biochemical studies [11^15] have indicated
that there is a direct interaction of helix 2 of TBP with TFIIA.
This interaction was not observed, however, in the TFIIA^
TBP^TATA crystal structures [3,4].
In addition to TBP, TFIID contains numerous other phy-
logenetically conserved subunits termed the TBP-associated
factors (TAFIIs) [16], which modulate the promoter recogni-
tion and transcriptional activities of TBP [17]. For example, in
yeast (y), Drosophila (d) and human (h), the largest TAFII
possesses an N-terminal inhibitory domain (NID) that blocks
TBP^TATA binding through direct interaction with TBP [18^
21]. The NID can be dissected into two subdomains, I and II
(residues 2^81 and 82^156 of dTAFII230) (Fig. 1A). We have
previously determined the three-dimensional structure of the
complex between TBP and dTAFII230 subdomain I, revealing
an elegant mechanism for autoinhibition in which subdomain
I occupies the concave DNA binding surface of TBP and
undergoes an extensive degree of induced folding to mimic
the partially unwound structure of a TBP-bound TATA ele-
ment [22].
TFIIA and TAFIIs are involved in a dynamic interplay to
regulate binding of TFIID to promoter DNA [15,23^29]. In
order to extend our understanding of the interplay between
TBP, inhibitory dTAFII230 and stimulatory TFIIA, and to
account for the discrepancy between biochemical and crystal-
lographic studies concerning the role of TBP helix 2 in bind-
ing TFIIA, we have measured peak attenuation and chemical
shift changes in nuclear magnetic resonance (NMR) spectra to
map the binding sites on yTBP of dTAFII230 NID subdomain
II (Fig. 1B) and yTFIIA (a heterodimer of 32 kDa TOA1 and
13.5 kDa TOA2) [30,31]. A study using peptides reported an
interaction between the helix 2 region of hTBP and the frag-
ment comprising residues 281^301 of the L subunit of hTFIIA
[32]. The present study was carried out with full-length
yTFIIA, however, and therefore presents a more complete
picture of TFIIA^TBP interactions. Our report also provides
structural evidence that TFIIA and dTAFII230 subdomain II
have overlapping binding sites on TBP, including helix 2. The
dynamics of both TFIIA^TBP and dTAFII230 subdomain II^
TBP interactions, evidenced by extensive broadening of TBP
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NMR signals in the binding region and unde¢ned electron
density in a TFIIA segment important for TBP binding
[4,33], hinder more detailed structural analysis. The high mo-
lecular weight (V74 kDa) of the TBP^dTAFII230(11^77)^
TFIIA complex is also a major hindrance to detailed struc-
tural study by NMR.
2. Materials and methods
2.1. Protein expression and puri¢cation
The protocols for obtaining the C-terminal core domain (residues
49^240) of Saccharomyces cerevisiae TBP (MW 21.3 kDa) and Dro-
sophila TAFII230(11^77) have been described previously [22].
dTAFII230(1^156) was puri¢ed in essentially the same manner as
dTAFII230(11^77) [22]. Since dTAFII230(1^156) is more acidic than
dTAFII230(11^77), however, the TBP^dTAFII230(1^156) complex
was separated from its unbound individual components by gel ¢ltra-
tion instead of cation exchange. S. cerevisiae TFIIA (full length TOA1
and TOA2 subunits, producing a heterodimer of total MW 45.5 kDa)
was expressed and puri¢ed as described previously [15]. Separation of
complexed from non-complexed TFIIA subunits and further puri¢ca-
tion was achieved by gel ¢ltration using Superdex 75 (Pharmacia).
2.2. NMR data collection and analysis
1H-15N heteronuclear single quantum coherence (HSQC) spectra
were recorded using a 500 MHz Varian INOVA spectrometer. All
spectra were recorded at 25‡C with 144 complex t1 increments of
1000 complex data points and 160 transients except in the second
and third points of the TFIIA titration where 216 and 232 transients
were recorded. Spectral widths were 32.7 ppm and 16.0 ppm for the
15N (F1) and 1H (F2) dimensions. NMR samples containing 15N TBP
in complex with either unlabelled dTAFII230(11^77) or unlabelled
dTAFII230(1^156) were prepared as described previously [22]. 1H-
15N HSQC peak intensities were obtained using Pipp [34] and nor-
malized by the intensity of a peak from a side chain NH2 group that is
expected to be unstructured in all samples.
The TFIIA titration was carried out as follows: a 15N TBP^
dTAFII230(11^77) NMR sample of about 0.5^0.7 mM was made
and its 1H-15N HSQC spectrum was recorded to verify the equiva-
lence of the sample to those used in our previous studies [22]. This
NMR sample was diluted from 0.5 ml to 2.5 ml using NMR sample
bu¡er [22] and TFIIA was then added dropwise to it. The sample was
then concentrated to 0.5 ml with a ¢nal TFIIA concentration of
approximately 0.11 mM. After recording a 1H-15N HSQC spectrum,
a second addition of TFIIA was carried out in the same manner as the
¢rst, giving a ¢nal TFIIA concentration of approximately 0.19 mM.
The third addition of TFIIA gave a ¢nal TFIIA concentration of
approximately 0.28 mM.
3. Results
The dTAFII230 subdomain II binding site on TBP was
de¢ned by comparing the 1H-15N HSQC spectrum of uni-
formly 15N-labelled TBP in the TBP^dTAFII230(1^156) com-
plex with the corresponding spectrum of TBP in the
dTAFII230(11^77) complex (Fig. 2A,B). Any noteworthy dif-
ferences between the two spectra were due to the presence of
subdomain II, residues 82^156, of dTAFII230. The most ob-
vious di¡erence noticed was the overall increase in linewidth
of NMR signals for the TBP^dTAFII230(1^156) complex
(data not shown), due to the increase in molecular weight of
the complex from about 28.5 kDa to 38 kDa. The selective
further broadening of certain TBP peaks illustrated in Fig. 2
arose from intermediate timescale exchange between TBP-
bound and unbound states of dTAFII230 subdomain II.
This contrasts with the tight TBP^dTAFII230 subdomain I
interaction (Kd in the low nM range) which is dominated by
hydrophobic contacts and exhibits slow exchange between
bound and unbound forms [22]. Thus, the two subdomains
of dTAFII230 simultaneously bind TBP with di¡erent time-
scales of chemical exchange between bound and unbound
forms. The TBP^dTAFII230 subdomain II interaction is
most probably dominated by electrostatic contacts given the
high proportion of acidic amino acids in subdomain II (33%
compared to 21% in subdomain I of dTAFII230; Fig. 1B), the
amphipathic, basic nature of the C-terminal half of TBP helix
2 and that mutation studies indicate that acidic residues in
yTAFII145 subdomain II contribute to the binding to TBP
[15]. A titration of TBP with dTAFII230(1^156) could not
be performed because free TBP is unstable and precipitates
readily under the bu¡er conditions and protein concentrations
used for the TBP^TAFII NMR samples, which are made by
mixing dilute TBP and TAFII.
The TFIIA binding site on TBP was mapped similarly, ex-
cept that the 15N TBP^dTAFII230(11^77) complex was ti-
trated with unlabelled TFIIA. A 1H-15N HSQC spectrum of
TBP was recorded at each titration point (Fig. 2A,C). Selec-
tive e¡ects were observed upon the ¢rst and second additions
of TFIIA, and most TBP HSQC peaks were broadened to or
close to the level of the spectral noise after the third addition
of TFIIA. The TBP^dTAFII230(11^77) complex provides an
excellent platform for investigating the interaction of TBP
with TFIIA in solution: the TBP^dTAFII230(11^77) complex
structurally resembles the TBP^DNA complex [22], the sam-
ple is su⁄ciently stable for detailed NMR studies and can be
routinely generated.
dTAFII230 subdomain II and TFIIA caused attenuation
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Fig. 1. Features of dTAFII230 and TOA1. A: Schematic depiction
of full-length dTAFII230. Proposed domain locations and functions
are shown. The N-terminal TBP inhibitory domain is highlighted in
yellow and the sequence locations of subdomains I and II are indi-
cated. The secondary structure of subdomain I is taken from a pre-
vious structural study [22]. B: Sequence alignment of dTAFII230
subdomain II and TOA1 residues 180^254. Identical amino acids
are highlighted in pink and conservatively substituted amino acids
in green. The region of TOA1 (residues 217^240) essential for for-
mation of stable TFIIA complexes with TBP and TBP^DNA [33] is
marked with a double-headed arrow and its putative interaction
with TBP helix 2 is indicated. Sequences were aligned using CLUS-
TAL W [40].
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(Fig. 2B,C) and/or chemical shift changes of the backbone
amide peaks of numerous residues in the N-terminal K/L-re-
peat motif of TBP, within the stretches Leu-87 to Glu-108 and
Lys-133 to Phe-152 (dTAFII230 subdomain II; Fig. 3), and
Thr-73 to Glu-108 and Gly-125 to Lys-145 (TFIIA; Fig. 4).
Since a signi¢cant chemical shift change or peak attenuation
indicates that the residue concerned is located at or close to
the intermolecular interface, these data indicate that
dTAFII230 subdomain II and TFIIA have overlapping bind-
ing sites on the TBP surface localized to the N-terminal K/L-
repeat motif. Leu-87 to Glu-108 includes the C-terminal part
of helix 1 (residues 82^89) and the N-terminal stirrup, and
Lys-133 to Phe-152 includes helix 2 (residues 129^146) and
the subsequent loop on the convex upper TBP surface (Fig.
3A). TFIIA exerted signi¢cant e¡ects also on TBP residues
preceding Leu-87, including the strand and loop leading to
helix 1 (Fig. 4A).
The strongest peak attenuation by TFIIA occurred at TBP
residues Leu-87, Arg-90 and Arg-141. Leu-87 and Arg-90 lie
in and just C-terminal to helix 1, while Arg-141 lies in helix 2
on the convex upper surface of TBP (Fig. 4). Within the frag-
ment from Thr-73 to Glu-108, TFIIA addition also signi¢-
cantly a¡ected TBP residues Asn-91, Glu-93 and Asn-95
and others in the vicinities of Lys-83, Arg-105 and Arg-107.
These e¡ects correlate well with the crystal structure of the
yTFIIA^yTBP^DNA complex [3,4], wherein the predominant
TFIIA^TBP binding interface involves the L-strand (amino
acids 91, 92 and 94) leading to the N-terminal TBP stirrup.
Generally, dTAFII230 subdomain II induced little or no
change in the chemical shifts of residues making up the con-
cave DNA binding surface of TBP, indicating that dTAFII230
subdomain II does not exert a signi¢cant widespread e¡ect on
the interaction between TBP and dTAFII230 subdomain I.
Met-104 and Ile-106 did, however, undergo relatively large
chemical shift changes, perhaps re£ecting a local structural
perturbation at an edge of the concave TBP L-sheet (Fig.
3A). The path of the N-terminal part of subdomain II inferred
from these and other e¡ects in the vicinity of the TBP N-
Fig. 2. dTAFII230 subdomain II and TFIIA interaction with TBP. A: 1H-15N HSQC spectrum of 15N-labelled TBP in complex with unlabelled
dTAFII230(11^77). The 15N TBP^dTAFII230(11^77) complex spectrum was used as reference for mapping the binding sites on TBP of
dTAFII230 subdomain II (B) and TFIIA (C). The peaks shown in B and C are boxed and labelled with the relevant TBP amino acid residue
name and sequence position. B: Examples of the selective TBP peak attenuation due to binding of dTAFII230 subdomain II (residues 82^156)
to TBP. Each row contains a TBP amino acid residue name and sequence position, the peak due to that residue from the spectrum shown in
A (3 column) followed by the corresponding peak from the 1H-15N HSQC spectrum of 15N-labelled TBP in complex with unlabelled
dTAFII230(1^156) (+ column). A blank in the + column indicates that the peak has been broadened to the level of the spectral noise. The
peaks are listed in decreasing order of subdomain II-induced attenuation. For example, the Lys-97 peak is broadened to the level of the spec-
tral noise, the Arg-196 peak is slightly attenuated and the Ser-53 peak is not attenuated at all. C: Examples of the selective TBP peak attenua-
tion due to binding of TFIIA to TBP in a three-point titration of TFIIA into a sample of 15N-labelled TBP complexed with unlabelled
dTAFII230(11^77). Each row contains a TBP amino acid residue name and sequence position, the peak due to that residue from the spectrum
shown in A followed by the corresponding peak from each of the 1H-15N HSQC spectra recorded at the three points in the TFIIA titration
with successively greater levels of TFIIA. The peaks are listed in decreasing order of TFIIA-induced attenuation.
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terminal stirrup (Fig. 3) is consistent with the proximal loca-
tion of the C-terminus of subdomain I observed in the struc-
ture of the TBP^dTAFII230 subdomain I complex [22].
dTAFII230 subdomain II and TFIIA e¡ects on several TBP
residues between Thr-73 and Glu-108 and in helix 2 could not
be ascribed due to peak overlap or absence from the TBP^
dTAFII230(11^77) spectrum. These included Ala-92 and Tyr-
94 and helix 2 basic residues Arg-137 and Lys-138; Lys-138
was part of the (Lys-133, 138, 145-Glu) mutation that weak-
ened TBP interaction with yTAFII145 NID, and the (Lys-138-
Thr, Tyr-139-Ala) and (Lys-133,138,145-Glu) mutations that
abolished TBP^DNA interaction with TFIIA [13,15].
4. Discussion
Structural knowledge of the interactions leading to repres-
sion, derepression and net activation of transcription is lim-
ited. TFIID^promoter interaction is a key process for tran-
scriptional regulation that can be rate limiting for
transcription in vivo [35^38]. Accordingly, numerous activa-
tors and repressors of transcription in£uence this step in RNA
polymerase II complex assembly. For example, the N-terminal
domain of the largest TAFII of yeast, Drosophila and human
TFIID strongly interacts with TBP and inhibits TBP function
[15,19,20,29,39]. Evidence from biochemical experiments sug-
gests that TFIIA supports activated transcription at least in
part by competing for binding to TBP with the NID of the
largest TAFII [15,29]. Our NMR-based observation that
yTFIIA and dTAFII230 subdomain II have overlapping bind-
ing sites on TBP, including helix 1, the subsequent loop to
strand 1, the N-terminal stirrup, strand 2 and notably helix 2
on the convex upper TBP surface (Figs. 3 and 4), provides
structural evidence in support of the biochemical evidence
[15,29] that TFIIA and subdomain II compete for access to
TBP. This indicates that subdomain II augments the inhibi-
tory e¡ect of subdomain I by hindering the TBP^TFIIA in-
teraction that stabilizes the TBP^DNA complex and supports
transcriptional activation.
The NMR data indicate that both TFIIA and dTAFII230
subdomain II contact helix 2 on the convex upper surface of
Fig. 3. dTAFII230 subdomain II interaction with TBP. A: Ribbon
representation of TBP taken from the structure of the complex be-
tween TBP and dTAFII230 subdomain I [22]. TBP residues most af-
fected by binding of dTAFII230 subdomain II, as determined by
NMR, are highlighted in red (strong e¡ect) and yellow (medium ef-
fect) and their sidechains are shown. B: Space-¢lling representation
of the complex between TBP (cyan) and dTAFII230(11^77) (dark
violet). The residues most a¡ected by binding of dTAFII230 subdo-
main II are highlighted in red (strong e¡ect) and yellow (medium ef-
fect) as in A. The inferred binding of dTAFII230 subdomain II to
TBP helix 2 is indicated. This ¢gure was created using MOL-
SCRIPT [41].
Fig. 4. TFIIA interaction with TBP. A: Ribbon representation of
TBP taken from the structure of the complex between TBP and
dTAFII230 subdomain I [22]. TBP residues most a¡ected by binding
of TFIIA, as determined by NMR, are highlighted in red (strong ef-
fect) and yellow (medium e¡ect) and their sidechains are shown.
B: Space-¢lling representation of the yTFIIA^yTBP^DNA complex
taken from the ternary complex crystal structure [4]. TBP is shown
in cyan, DNA in orange and the TOA1 and TOA2 subunits of
yTFIIA as light and dark green ribbons. TBP residues a¡ected by
TFIIA binding in solution are shown in red (strong e¡ect) and yel-
low (medium e¡ect) as in A. Full-length TOA1 and TOA2 were
used in this NMR study. TOA1 residues 210^240, not well de¢ned
in the electron density map [4], are represented by a light green
dashed line with residues 217^240, required for stable TFIIA^TBP
or TFIIA^TBP^DNA complex formation [33], highlighted. TOA1
used for crystallization contained a large central deletion between
residues 55 and 207 [4] or between 95 and 209 [3]. This deleted re-
gion is represented by a black dashed line. This ¢gure was created
using MOLSCRIPT [41].
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TBP, probably primarily through basic TBP residues such as
Lys-138 (amide peak absent from TBP HSQC spectrum), Arg-
141 and Lys-145 (amide peaks attenuated by TFIIA). This
result is consistent with previous biochemical in vitro results
[11,12,14] and genetic in vivo results [13] which suggested that
TBP helix 2 is important for interaction with TFIIA. How-
ever, no TBP helix 2^TFIIA contact was observed in the
yTFIIA^yTBP^DNA complex crystal structures [3,4]. Geiger
et al. [3] suggested that the human and yeast TBP^TFIIA
complexes di¡er and proposed that only human complex in-
cludes an interaction between TFIIA and TBP helix 2. Alter-
natively, residues 210^240 of the larger TFIIA subunit, TOA1
(Fig. 4B), poorly de¢ned in the electron density map, may
form a ‘long shoelace’ that contacts TBP helix 2 and subse-
quently wraps around TBP to contact the side of TBP helix 1
[4]. This possibility is supported by several observations, in-
cluding: TOA1 residues 217^240 are necessary for the forma-
tion of stable TFIIA^TBP and TFIIA^TBP^DNA complexes
[33]; the proposed path has several basic TBP residues to
complement the highly acidic TOA1 shoelace (sequence
shown in Fig. 1B); and the yTBP helix 2 double mutation
Lys-138-Thr, Tyr-139-Ala weakens or abolishes yTBP^
yTFIIA interaction in vitro and in vivo [13]. By indicating
that yTFIIA does contact TBP helix 2, our results are con-
sistent with these observations. In further support of the pro-
posed [4] path of TOA1 residues 210^240, TFIIA a¡ects TBP
helix 1 residues (Fig. 4A,B), indicating that yTFIIA also con-
tacts TBP helix 1. The sequence similarity of subdomain II
and TOA1 residues 210^240 (Fig. 1B), particularly the acidic
character, is consistent with similar paths along the TBP sur-
face. In support of the proposal by Geiger et al. [3], some of
the previous biochemical results [11] indicate that hTFIIA
may make more extensive contacts than yTFIIA with TBP
helix 2, although con¢rmation requires structural analysis of
a human TFIIA^TBP^DNA complex.
The lack of TFIIA^TBP helix 2 contacts in the ternary
complex crystal structures may arise from the large central
deletion (residues 95^209 or 55^207) in the TOA1 subunit
used for crystallization [3,4], resulting in two polypeptides
(TOA1N and TOA1C in Fig. 4B). This may a¡ect the con-
formation of the fragment (residues 217^240) required for
formation of stable TFIIA complexes with TBP and TBP^
DNA [33], since this fragment is close to the N-terminus of
TOA1C. It might conversely be argued that the TBP^TFIIA
contacts determined by NMR, using TBP^dTAFII230(11^77)
instead of TBP^TATA as a platform, do not necessarily re-
£ect the TBP^TFIIA contacts in a TFIIA^TBP^TATA com-
plex. The TFIIA-induced changes in TBP NMR spectra dis-
cussed above, however, indicate that TBP^TFIIA contacts in
the TBP^dTAFII230(11^77) complex correspond to those ob-
served in the TFIIA^TBP^TATA crystal structures, with the
major exception of the helix 1 and helix 2 contacts.
The results of this and other studies [15,21,22] indicate that
VP16 activation domain and yTAFII145/dTAFII230/
hTAFII250 subdomain I compete for binding to the concave
undersurface of TBP, whereas TFIIA and yTAFII145/
dTAFII230/hTAFII250 subdomain II compete for binding to
the convex upper surface of TBP. These observations lead to
an appealing model in which the repressive TBP^yTAFII145/
dTAFII230/hTAFII250 interaction is counteracted by TFIIA
in concert with one or more activators, the latter to relieve the
inhibitory TAFII interaction on the TBP concave surface,
TFIIA to relieve the inhibitory TAFII interaction on the con-
vex TBP surface. It remains unclear how the DNA binding
surface of TBP is subsequently released to permit the slow
association of TBP with DNA without allowing the presum-
ably more facile inhibitory TBP^TAFII interaction to re-oc-
cur.
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